This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

Facial Interfaces (Masks and Humidifiers)) Markets

Independently Analyzed with Annual Sales in US$ Million for

Years 2010 through 2018 (includes corresponding Graph/Chart) III-59

Table 76: Rest of World Historic Review for Sleep ApneaDiagnostic and Therapeutic Devices by Product Segment -Diagnostic Devices (Clinical/ Fixed PSG, Ambulatory PSG, andOthers (Screening Devices)), and Therapeutic Devices (CPAP,Auto PAP, Bi-Level PAP, and Facial Interfaces (Masks andHumidifiers)) Markets Independently Analyzed with AnnualSales in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-60

Table 77: Rest of World 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

Percentage Breakdown of Value Sales for Diagnostic Devices

(Clinical/Fixed PSG, Ambulatory PSG, and Others (Screening

Devices)), and Therapeutic Devices (CPAP, Auto PAP, Bi-Level

PAP, and Facial Interfaces (Masks and Humidifiers)) Markets

for Years 2004, 2011, and 2018 (includes corresponding

Graph/Chart) III-61


Total Companies Profiled: 68 (including Divisions/Subsidiaries - 106)

The United States (51) Canada (4) Japan (2) Europe (31)- France (4)- Germany (8)- The United Kingdom (5)- Italy (2)- Spain (3)- Rest of Europe (9) Asia-Pacific (Excluding Japan) (13) Latin America (2) Middle East (3)

To order this report: Pathology Industry: Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
16 of 16

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs